Hi wesso
I just want to see clear direction fundamentally in terms of immunotherapies
Clear progression
I don't want to outlay more cash and have a dud HSV because traders will sell imo
I'll be happier to be certain than risk having to find an exit
I'm wrong plenty of times and I think I'm more mature protecting my cash now than ever
If we have clear progression of a trial and collaboration or partnership and the price has support then I'll feel more confident buying after the web
Cheers
What do you think man?
Ann: HSV-2 Phase IIa Results Investor Webinar, page-127
-
- There are more pages in this discussion • 170 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.31 |
Change
0.000(0.00%) |
Mkt cap ! $351.9M | |||
| Open | High | Low | Value | Volume |
| $18.30 | $19.00 | $18.00 | $363.4K | 19.82K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 500 | $18.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.50 | 1000 | 1 |
View Market Depth
| Last trade - 15.59pm 01/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |